MedPath

A study to review safety profile of patients who have received two different types of pain control management

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/01/030655
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients administered combined epidural and intravenous patient-controlled analgesia at

TMH from 1st Jan 2019 till 31st Dec 2019

Exclusion Criteria

cases with missing data

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of combined epidural and intravenous patient-controlled analgesia in surgical patientsTimepoint: Until Post op 6 days
Secondary Outcome Measures
NameTimeMethod
Associated side effects and safety profile of combined epidural and intravenous patient controlled analgesia practices in the post-operative periodTimepoint: Until Post op 6 days;Number of days of use of combined epidural and intravenous patient-controlled analgesia in surgical patientsTimepoint: Until Post op 6 days
© Copyright 2025. All Rights Reserved by MedPath